After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

GSK Trading Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1.0 lakhs and has 100 ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Bagri now forecasts that the pharmaceutical company will post earnings of $1.03 per share for the quarter, down from their previous forecast of $1.10. The consensus estimate for GSK’s current ...

LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company's website today and is also set to ...

We have a vested interest being shareholders in GSK but its really sad situation. I expect there to be a pushback over the next few days. 'British drugmaker GSK will no longer set diversity targets'.

The firm owned 20,765 shares of the pharmaceutical company’s stock after selling 5,040 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in GSK were worth $702,000 as of its ...

Analysts are pounding the table on these tech stocks.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

Tony Wood, GSK’s chief scientific officer, acknowledged it might be easier to communicate the company’s potential if he could point to “one big drug”, but said: “It is in some ways an ...

The minister disclosed this following a meeting with senior company representatives at Vidhana ... Krones' Rs 315 crore manufacturing plant at Vemagal, another key investment stemming from GIM.